InsiderClue
Insiders · Profile

Nanavaty Maulik

Director at Rani Therapeutics · SVP & Pres, Neuromodulation at Boston Scientific. Filing since 29 May 2015. CIK 0001529708

RANI Rani Therapeutics Holdings, Inc. Director · 1 trade BSX Boston Scientific SVP & Pres, Neuromodulation · 22 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RANI Rani Therapeutics Holdings, Inc.
16 Nov 2023
Director
Bought
500
$990.00
opened
BSX Boston Scientific
28 May 2021
SVP & Pres, Neuromodulation
Sold, plan not stated
78,192
$3.33M
31.9%
BSX Boston Scientific
28 Aug 2020
SVP & Pres, Neuromodulation
Sold, plan not stated
38,000
$1.54M
14.2%
BSX Boston Scientific
2 Mar 2020
SVP & Pres, Neuromodulation
Sold, plan not stated
16,763
$628.18K
6.1%
BSX Boston Scientific
3 Feb 2020
SVP & Pres, Neuromodulation
Sold, plan not stated
9,623
$405.80K
3.6%
BSX Boston Scientific
3 Jan 2020
SVP & Pres, Neuromodulation
Sold, plan not stated
5,025
$224.76K
1.9%
BSX Boston Scientific
2 Jan 2020
SVP & Pres, Neuromodulation
Sold, plan not stated
9,623
$436.21K
3.6%
BSX Boston Scientific
4 Dec 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
9,623
$412.71K
3.6%
BSX Boston Scientific
27 Nov 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
20,552
$889.32K
7.5%
BSX Boston Scientific
4 Nov 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
9,623
$400.89K
3.6%
BSX Boston Scientific
3 Oct 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
9,623
$377.74K
3.6%
BSX Boston Scientific
29 Aug 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
34,035
$1.45M
11.8%
BSX Boston Scientific
17 Jun 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
3,039
$122.96K
1.2%
BSX Boston Scientific
15 May 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
3,038
$111.62K
1.2%
BSX Boston Scientific
15 Apr 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
3,039
$114.90K
1.2%
BSX Boston Scientific
15 Mar 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
3,038
$121.85K
1.2%
BSX Boston Scientific
15 Feb 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
3,039
$122.53K
1.2%
BSX Boston Scientific
15 Jan 2019
SVP & Pres, Neuromodulation
Sold, plan not stated
3,038
$107.73K
1.2%
BSX Boston Scientific
16 Nov 2018
SVP & Pres, Neuromodulation
Sold, plan not stated
23,458
$874.45K
9.1%
BSX Boston Scientific
9 Feb 2018
SVP & Pres, Neuromodulation
Sold, plan not stated
15,568
$395.11K
6.8%
BSX Boston Scientific
31 Aug 2017
SVP & Pres, Neuromodulation
Sold, plan not stated
30,000
$823.54K
12.6%
BSX Boston Scientific
30 Aug 2017
SVP & Pres, Neuromodulation
Sold, plan not stated
27,031
$732.08K
11.5%
BSX Boston Scientific
29 May 2015
SVP & Pres, Neuromodulation
Sold, plan not stated
71,558
$1.33M
34.7%
23 decisions on file.